| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Financial Officer | Stock Option (right to buy) | 300,000 | 06 Aug 2025 | Direct | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Financial Officer | Restricted Stock Units | 150,000 | 06 Aug 2025 | Direct | ||
| CG Oncology, Inc. | CFO | Employee Stock Option (Right to Buy) | 143,907 | 15 Apr 2025 | Direct | ||
| CG Oncology, Inc. | CFO | Stock Option (Right to Buy) | 93,600 | 04 Oct 2024 | Direct | ||
| Immunome Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 58,000 | 08 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 06 Aug 2025 | 2 | $0 | 4 | Chief Financial Officer | 08 Aug 2025, 16:06 |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 06 Aug 2025 | 0 | $0 | 3 | Chief Financial Officer | 08 Aug 2025, 16:05 |
| CGON | CG Oncology, Inc. | 15 Apr 2025 | 1 | $0 | 4 | CFO | 16 Apr 2025, 16:15 |
| CGON | CG Oncology, Inc. | 04 Oct 2024 | 1 | $0 | 4 | CFO | 08 Oct 2024, 09:29 |
| CGON | CG Oncology, Inc. | 29 Jan 2024 | 1 | +$38,000 | 4 | CFO & Secretary | 31 Jan 2024, 16:30 |
| CGON | CG Oncology, Inc. | 24 Jan 2024 | 1 | $0 | 4 | CFO & Secretary | 26 Jan 2024, 16:30 |
| CGON | CG Oncology, Inc. | 24 Jan 2024 | 0 | $0 | 3 | CFO & Secretary | 24 Jan 2024, 21:03 |
| IMNM | Immunome Inc. | 08 Jun 2023 | 1 | $0 | 4 | Chief Financial Officer | 12 Jun 2023, 16:58 |
| IMNM | Immunome Inc. | 16 Jun 2022 | 1 | $0 | 4 | Chief Financial Officer | 21 Jun 2022, 18:06 |
| IMNM | Immunome Inc. | 28 May 2021 | 1 | $0 | 4 | Chief Financial Officer | 01 Jun 2021, 19:21 |